Stay updated on Secukinumab in Non-Radiographic Axial Spondyloarthritis Clinical Trial
Sign up to get notified when there's something new on the Secukinumab in Non-Radiographic Axial Spondyloarthritis Clinical Trial page.

Latest updates to the Secukinumab in Non-Radiographic Axial Spondyloarthritis Clinical Trial page
- Check4 days agoChange DetectedThe footer's site revision changes from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check11 days agoChange DetectedA sitewide NIH notice was added above the 403 response, linking to transition updates and stating that NIH is adopting “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check18 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1 while the page continues to show a 403 error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating access is blocked to the study record. The error page includes a 403 message and a Home button, replacing the previous study content.SummaryDifference19%

- Check67 days agoChange DetectedA new site revision tag Revision: v3.6.6 appears on the page, replacing Revision: v3.6.5. This indicates a minor version update to the site rendering.SummaryDifference0.0%

Stay in the know with updates to Secukinumab in Non-Radiographic Axial Spondyloarthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab in Non-Radiographic Axial Spondyloarthritis Clinical Trial page.